Position in CLDX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$230,850
+$507 QoQ
Shares Held
6,204
-26.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#176
of 252 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Argent Trust Co holds $4,756,008 across 11 Biotechnology names. CLDX ranks #9 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,749 | $1,090,571 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,014 | $1,000,412 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
1,426 | $530,001 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,220 | $385,629 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
5,598 | $307,553 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,174 | $287,359 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
3,018 | $239,296 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
2,679 | $232,938 |
All Filings in CLDX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,850 | 6,204 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $230,343 | 8,481 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $219,403 | 8,481 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||